Streptococcosis in Farmed Fish: Streptococcus iniae and S. agalactiae Infections

Introduction

Streptococcosis represents a major infectious disease syndrome in global finfish aquaculture, primarily caused by the Gram positive cocci Streptococcus iniae and Streptococcus agalactiae (Group B Streptococcus, GBS). These pathogens are responsible for devastating outbreaks in warm and cool water species, notably Nile tilapia (Oreochromis niloticus), rainbow trout (Oncorhynchus mykiss), and yellow catfish (Pelteobagrus fulvidraco). The economic impact stems from high mortality rates, chronic morbidity, and the costs associated with antimicrobial treatment and biosecurity interventions. Recent genomic surveillance has documented the global dissemination of specific clonal lineages, including S. agalactiae serotype Ia ST7 CC1 in Latin America [1] and the emergence of sequence type 283 (ST283) as a foodborne zoonotic pathogen [2]. This article provides a clinical and molecular reference for the diagnosis, pathogenesis, and control of streptococcosis in farmed fish, with a focus on S. iniae and S. agalactiae.

Etiology and Genomic Epidemiology

Streptococcus agalactiae

S. agalactiae is a beta-hemolytic, Lancefield group B streptococcus that exhibits substantial capsular polysaccharide diversity. The predominant serotypes affecting fish include Ia, Ib, and III, with serotype Ia demonstrating a particularly high virulence in Nile tilapia. Molecular typing using multilocus sequence typing (MLST) has revealed a clonal expansion of sequence type 7 (ST7) within clonal complex 1 (CC1) in Latin American aquaculture [1]. This lineage is associated with age-dependent disease expression, where juvenile fish display acute septicemia while adults develop chronic meningoencephalitis. In parallel, ST283 has been recognized as an emerging foodborne zoonotic pathogen, capable of causing disease in humans following the consumption of contaminated raw fish [2]. Non-tilapia freshwater fish, including hybrid marbled goby (Oxyeleotris marmoratus), have also been identified as susceptible hosts, indicating an expanding host range [3, 4].

Streptococcus iniae

S. iniae is a non-Lancefield, beta-hemolytic streptococcus that remains a primary pathogen in Asian and Mediterranean aquaculture. The species demonstrates substantial genetic diversity, with sequence type 4 (ST4) isolates from diseased yellow catfish exhibiting a high density of virulence-associated genes and multidrug resistance determinants [5]. Comparative genomics has demonstrated that S. iniae encodes a suite of secreted and surface-associated virulence factors, including capsular polysaccharide, streptolysin S, and M-like surface proteins that facilitate immune evasion and tissue invasion.

Clinical Signs and Pathology

The clinical presentation of streptococcosis varies with host species, age, and water temperature. Acute outbreaks are characterized by sudden high mortality with minimal clinical signs, whereas subacute to chronic infections manifest as a classic neurotropic syndrome.

Table 1: Clinical Signs of Streptococcosis in Farmed Fish

On necropsy, the most consistent lesions include splenomegaly, renomegaly, and meningeal congestion. Histopathology reveals a severe, pyogranulomatous meningoencephalitis with bacterial emboli within cerebral vessels. In S. agalactiae infections, interstitial myocarditis and epicarditis are common findings. The tropism for central nervous system tissue is mediated by bacterial adhesion to the blood-brain barrier endothelium, facilitated by surface proteins such as fibrinogen-binding proteins and the laminin-binding protein (Lmb).

Pathogenesis and Host-Pathogen Interactions

Immune Evasion Mechanisms

S. agalactiae and S. iniae employ multiple strategies to subvert the host immune response. The capsular polysaccharide of S. agalactiae reduces opsonophagocytosis by masking surface antigens. The bacteria also secrete a C5a peptidase that cleaves the complement chemoattractant, impairing neutrophil recruitment. In tilapia, the interferon regulatory factor 5 (IRF5) pathway is activated following S. agalactiae infection, leading to the upregulation of pro-inflammatory cytokines [6]. Concurrently, the host ISG15 system modulates the antiviral and antibacterial response, suggesting a complex interplay between innate immune activation and bacterial countermeasures [7].

Transcriptional Reprogramming

Infection-induced transcriptional changes in the spleen of Nile tilapia have been characterized through genome-wide analysis of the interleukin gene family. S. agalactiae challenge results in the differential expression of multiple interleukins, including IL-1beta, IL-6, and IL-10, reflecting a mixed pro-inflammatory and regulatory response [8]. This cytokine milieu contributes to the pathological inflammation observed in the meninges and myocardium.

Diagnostic Approaches

Bacteriological Culture

Conventional diagnosis relies on the isolation of the pathogen from brain, kidney, and spleen tissue. Samples are plated on Columbia blood agar or tryptic soy agar supplemented with 5% sheep blood and incubated at 28-30 degrees Celsius for 24-48 hours. S. agalactiae produces a narrow zone of beta-hemolysis, whereas S. iniae often displays a broader zone. Gram staining reveals Gram positive cocci in chains. Biochemical identification using commercial kits confirms esculin hydrolysis, arginine dihydrolase activity, and sugar fermentation profiles. However, phenotypic methods cannot reliably discriminate between serotypes or sequence types.

Molecular Diagnostics

Polymerase chain reaction (PCR) and quantitative PCR (qPCR) have become the gold standard for species-specific detection. The SaSi qPCR assay represents a recently developed duplex platform for the simultaneous detection and differentiation of S. agalactiae and S. iniae directly from fish tissue homogenates [9]. This assay targets species-specific genes, eliminating the need for culture enrichment and reducing time to diagnosis to under two hours. High-resolution melting analysis and multiplex PCR panels further enable serotype-level discrimination.

Table 2: Comparison of Diagnostic Methods for Fish Streptococcosis

Serological Assays

Antibody detection using enzyme-linked immunosorbent assay (ELISA) technology provides a means for herd-level surveillance of vaccine-induced immunity or past exposure. Recombinant phage-display monoclonal antibodies against fish IgM have enabled quantitative ELISA platforms that measure humoral responses following vaccination [10]. For antigen detection, monoclonal antibodies targeting surface proteins of S. agalactiae are used in capture ELISA formats, analogous to the diagnostics applied for other pathogens such as Feline Leukemia Virus. However, the sensitivity of antigen detection in carrier fish remains lower than that of nucleic acid amplification methods.

Antimicrobial Susceptibility Testing

The emergence of antimicrobial resistance in streptococcal isolates is a growing concern. Disk diffusion and broth microdilution assays, following Clinical and Laboratory Standards Institute guidelines, are standard for resistance profiling. S. agalactiae isolates from Latin America have demonstrated resistance to tetracycline and erythromycin, while S. iniae ST4 isolates exhibit multidrug resistance [1, 5]. The use of natural compounds such as silymarin has been investigated as an adjuvant to preserve the efficacy of quinolone and sulfonamide antibiotics in S. agalactiae infected tilapia [11].

Disease Management and Control

Antimicrobial Therapy

Therapeutic intervention relies on in-feed administration of oxytetracycline, florfenicol, or amoxicillin. The selection of antimicrobials must be guided by susceptibility testing to avoid the propagation of resistance. Furthermore, the role of Antimicrobial Resistance in Livestock-Associated Staphylococcus aureus serves as a parallel narrative for the need for prudent antibiotic use in aquaculture. The co-occurrence of other bacterial infections, such as Aeromonas hydrophila Infections in Aquaculture, complicates treatment regimens.

Vaccine Development

Vaccination remains the most sustainable strategy for streptococcosis control. Several vaccine platforms are under development:

Bacterin Vaccines. Formalin-killed whole-cell bacterins have been used for decades but provide limited cross-protection against heterologous serotypes. The immunogenicity of these vaccines can be enhanced through the inclusion of adjuvants such as mineral oil or nano-selenium particles. Selenium nano-vaccines have been shown to improve hematological biomarkers and immune biochemical activity in tilapia challenged with Streptococcus species [12].

Subunit Vaccines. Recombinant proteins, including surface immunogenic protein (SIP), enolase, and glyceraldehyde-3-phosphate dehydrogenase (GAPDH), have been evaluated as candidate antigens against S. iniae in four-finger threadfin (Eleutheronema tetradactylum). Multivalent formulations containing SIP plus enolase or GAPDH induce higher antibody titers and confer 70-85% relative percent survival following homologous challenge [13].

Locally Produced Autogenous Vaccines. For smallholder and regional producers, locally produced formalin-inactivated autogenous vaccines offer a practical alternative to commercial products. These vaccines are prepared from regional isolates and have demonstrated efficacy in reducing mortality in farmed tilapia [14].

Adjuvanted and Nano-Formulations. The use of immunostimulants such as beta-glucans and selenium nanoparticles as vaccine carriers potentiates the cellular and humoral arms of the immune response. Selenium nano-vaccines enhance phagocytic activity and serum lysozyme levels [12].

Figure 1: Vaccine Development Workflow for Fish Streptococcosis

flowchart TD
    A[Isolation of Field Strain], > B[Genomic Characterization: Serotype, ST]
    B, > C{Antigen Selection}
    C, > D[Bacterin: Formalin Inactivated Whole Cell]
    C, > E[Subunit: Recombinant SIP, Enolase, GAPDH]
    C, > F[DNA/RNA Vaccine]
    D, > G[Adjuvant Formulation: Oil/ Nano-Se/ Beta-glucan]
    E, > G
    F, > G
    G, > H[In vivo Efficacy Trial: Tilapia / Threadfin]
    H, > I{Protection >= 70% RPS?}
    I, > |Yes| J[Field Validation & Licensing]
    I, > |No| C

Emerging Threats and Host Range Expansion

The host range of S. agalactiae continues to expand. Recent reports have documented the first case of streptococcosis in hybrid marbled goby, indicating that non-traditional aquaculture species are at risk [4]. Additionally, the zoonotic potential of ST283 underscores the need for a One Health approach to surveillance. The cross-species transmission of S. agalactiae from fish to humans mirrors the patterns observed in other emerging zoonotic pathogens, such as Avian Influenza H5N1 in Dairy Cattle. The detection of GBS in non-tilapia freshwater fish further highlights the importance of molecular surveillance across different aquatic environments [3].

Virulence gene profiling of S. agalactiae from non-tilapia hosts reveals a conserved set of genes including cylE, cfb, and hylB, which are associated with hemolysin production and tissue degradation [3]. The age-dependent expression of disease in Latin American tilapia suggests that host susceptibility factors, such as the maturation of the blood-brain barrier, play a role in clinical outcome [1].

Immunomodulatory Host Factors

The host response to S. agalactiae is governed by a complex network of immune genes. Characterization of the interleukin gene family in Nile tilapia spleen has identified 18 interleukin genes that are differentially expressed during acute infection [8]. Of these, IL-1beta and IL-8 are rapidly upregulated, while IL-10 and TGF-beta show delayed expression, reflecting the shift from pro-inflammatory to regulatory responses. The functional characterization of IRF5 demonstrates its role as a master regulator of type I interferon and pro-inflammatory cytokine transcription [6]. Silencing of IRF5 results in increased bacterial load and mortality, confirming its essential role in antibacterial defense.

Conclusion

Streptococcosis caused by S. iniae and S. agalactiae remains a dominant challenge in farmed fish production worldwide. The disease pathogenesis involves a combination of bacterial virulence factors and host immune dysregulation, culminating in meningoencephalitis and high mortality. Progress in molecular diagnostics, particularly through duplex qPCR assays such as SaSi, has enabled rapid and accurate pathogen detection [9]. Vaccine development has advanced from simple bacterins to rationally designed subunit and nano-adjuvanted formulations, although cross-serotype protection remains an elusive goal [13, 12]. The emergence of zoonotic lineages and the expansion of host range necessitate continued genomic surveillance and the integration of bioinformatics tools for outbreak prediction. Future control strategies must emphasize biosecurity, prudent antimicrobial use, and the deployment of regionally tailored vaccines.

References

[1] Rozas-Serri M, Fernandez-Alarcon M, Miyoko-Natori M, et al. Streptococcus agalactiae Serotype Ia ST7 CC1 in Farmed Nile Tilapia in Latin America: Age-Dependent Disease Expression and Antimicrobial Susceptibility of an Emerging Clonal Lineage. Pathogens. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42198670/

[2] Abdulrahim A, Zadoks RN, Barkham T, et al. Rethinking Group B Streptococcus: The Rise of Sequence Type 283 as a Foodborne Zoonotic Pathogen. Compr Rev Food Sci Food Saf. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41981867/

[3] Hoai TD, Hoa DT, Anh NT, et al. Serotypes and Virulence Gene Profiles of Streptococcus agalactiae Isolates From Non-Tilapia Freshwater Fish. J Fish Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41622583/

[4] Wu W, Xu R, Sun Y, et al. Expansion of host range for Streptococcus agalactiae: first case in hybrid marbled goby (Oxyeleotris marmoratus female x Oxyeleotris lineolatus male) from aquaculture. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41557120/

[5] Lan T, Lin L, Wu T, et al. Virulence, genomic features, and antimicrobial resistance of a highly virulent Streptococcus iniae ST4 from diseased yellow catfish. Microb Pathog. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41935707/

[6] Wei Y, Tan H, Gu C, et al. Characterization and functional analysis of the interferon regulatory factor 5 (IRF5) from the GIFT Oreochromis niloticus. Dev Comp Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41921286/

[7] Wang Y, Tang W, Wu G, et al. Identification of an isg15 gene in Nile tilapia (Oreochromis niloticus) and analysis of its role in immune response modulation. Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41708017/

[8] Wang Z, Huang S, Liu H, et al. Genome-wide characterization of the interleukin gene family in Nile tilapia (Oreochromis niloticus) spleen: identification, expression dynamics, and regulatory mechanism during Streptococcus agalactiae infection. Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41391594/

[9] Taengphu S, Dong HT, Meemetta W, et al. SaSi qPCR: a novel duplex qPCR assay for rapid and simultaneous detection of Streptococcus agalactiae and Streptococcus iniae in fish. BMC Res Notes. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41327378/

[10] Sohn MY, Hikima JI, Kang G, et al. Recombinant phage-display monoclonal antibody against starry flounder (Platichthys stellatus) IgM enables quantitative ELISA for vaccine-induced humoral responses. Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41534741/

[11] Haggag NA, Elbadawy M, ElKomy A, et al. Silymarin conserves the efficacy of quinolone and sulfonamide in Nile tilapia (Oreochromis niloticus) subjected to aflatoxicosis and Streptococcus agalactiae infection. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42230695/

[12] Nasr-Eldahan S, Nabil-Adam A, Shreadah MA, et al. Effect of selenium nano-vaccine on hematological biomarkers and immune biochemical activity of nile tilapia (Oreochromis niloticus) challenged with Streptococcus pyogenes. Sci Rep. 2025. URL: https://pubmed.ncbi.nlm.nih.gov/41272054/

[13] Giovanni A, Shi YZ, Wang PC, et al. Evaluation of recombinant SIP, enolase, and GAPDH as subunit vaccine candidates against Streptococcus iniae in four-finger threadfin (Eleutheronema tetradactylum): Immunogenicity, protective efficacy, and multivalent potential. Fish Shellfish Immunol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41577307/

[14] Vinh NT, Dong HT, Turner JK, et al. Back to basics: locally produced vaccines offer a practical alternative to antibiotics for prevention of streptococcosis in farmed tilapia (Oreochromis spp.). Front Vet Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41815501/

[15] Avila-Castillo RA, Del Rio-Rodriguez RE, Soto-Rodriguez SA, et al. Confirmed Outbreaks of Streptococcosis Caused by Streptococcus agalactiae Serotype Ia in Nile Tilapia Culture From Campeche, Mexico. J Fish Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/41844281/